Findings from burn study demonstrate advantage of Apligraf + autograft versus autograft alone March 8, 1999 No Comments
Available for licensing from BTG: immune function modulator with applications in dermatology March 5, 1999 No Comments
New combination product represents a highly effective approach to acne vulgaris Feb. 23, 1999 No Comments
Available for licensing from VUFB: dopamine agonist for dermatology, gastrointestinal indications Feb. 19, 1999 No Comments
Fresenius will distribute Genzyme's Sepra products in select European markets Feb. 17, 1999 No Comments
RSS